Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system
- PMID: 3133812
Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system
Abstract
We analyzed fibrinolytic parameters in 20 healthy men and 20 healthy women, aged from 25 to 59, before and after 10 and 20 min venous occlusion. The 10 min post-occlusion fibrinolytic activity measured directly in diluted unfractionated plasma by a highly sensitive 125I-fibrin plate assay correlated well with the activity of euglobulins determined by the classical fibrin plate assay (r = 0.729), but pre-stasis activities determined with these two methods did not correlate (r = 0.084). The enhancement of fibrinolytic activity after venous occlusion was mainly due to an increase of t-PA in the occluded vessels (4-fold increase t-PA antigen after 10 min and 8-fold after 20 min venous occlusion). Plasminogen activator inhibitor (PAI) activity and plasminogen activator inhibitor 1 (PAI-1)1 antigen levels at rest showed considerable dispersion ranging from 1.9 to 12.4 U/ml, respectively 6.9 to 77 ng/ml. A significant increase of PAI-1 antigen levels was observed after 10 and 20 min venous occlusion. At rest no correlation was found between PAI activity or PAI-1 antigen levels and the fibrinolytic activity measured by 125I-FPA. However, a high level of PAI-1 at rest was associated with a high prestasis antigen level of t-PA and a low fibrinolytic response after 10 min of venous stasis. Since the fibrinolytic response inversely correlated with PAI activity at rest, we conclude that its degree depends mainly on the presence of free PAI.
Similar articles
-
Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.Thromb Haemost. 1988 Dec 22;60(3):361-4. Thromb Haemost. 1988. PMID: 3149043
-
Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and females.Thromb Haemost. 1991 Nov 1;66(5):581-5. Thromb Haemost. 1991. PMID: 1803623
-
Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.Thromb Haemost. 1992 Apr 2;67(4):397-401. Thromb Haemost. 1992. PMID: 1631786
-
Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.Dan Med Bull. 1993 Sep;40(4):383-408. Dan Med Bull. 1993. PMID: 8222763 Review.
-
The role of fibrinolytic factors in ischaemia.Eye (Lond). 1991;5 ( Pt 2):159-69. doi: 10.1038/eye.1991.30. Eye (Lond). 1991. PMID: 2070877 Review.
Cited by
-
Tissue-type plasminogen activator is a neuroprotectant in the central nervous system.Front Cell Neurosci. 2015 Aug 17;9:304. doi: 10.3389/fncel.2015.00304. eCollection 2015. Front Cell Neurosci. 2015. PMID: 26347605 Free PMC article. Review.
-
Prothrombotic abnormalities in inflammatory bowel disease.Dig Dis Sci. 1989 Jul;34(7):1089-93. doi: 10.1007/BF01536380. Dig Dis Sci. 1989. PMID: 2743849
-
The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis.Ann Surg. 1997 Sep;226(3):306-13; discussion 313-4. doi: 10.1097/00000658-199709000-00010. Ann Surg. 1997. PMID: 9339937 Free PMC article. Clinical Trial.
-
Catheter directed compared to systemically delivered thrombolysis for pulmonary embolism: a systematic review and meta-analysis.J Thromb Thrombolysis. 2022 Feb;53(2):454-466. doi: 10.1007/s11239-021-02556-7. Epub 2021 Aug 31. J Thromb Thrombolysis. 2022. PMID: 34463919
-
The urokinase plasminogen activator (u-PA) and its inhibitor (PAI-1) in embryo-fetal bone formation in the human: an immunohistochemical study.Anat Embryol (Berl). 1995 Oct;192(4):363-8. doi: 10.1007/BF00710105. Anat Embryol (Berl). 1995. PMID: 8554169
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous